A Study of Sweat Testing Using a Quantitative Patch
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01345617 |
Recruitment Status :
Completed
First Posted : May 2, 2011
Last Update Posted : August 29, 2018
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Cystic Fibrosis |
Study Type : | Observational |
Actual Enrollment : | 170 participants |
Observational Model: | Case-Control |
Time Perspective: | Prospective |
Official Title: | A Study of Sweat Testing Using a Quantitative Patch |
Study Start Date : | January 2012 |
Actual Primary Completion Date : | October 2013 |
Actual Study Completion Date : | October 2013 |

Group/Cohort |
---|
cystic fibrosis patients
cystic fibrosis patients
|
non-cystic fibrosis patients
non-cystic fibrosis patients
|
- sweat chloride value [ Time Frame: once, at enrollment (baseline) ]Sweat chloride measurements obtained by GCQPIT and CFQT
- QNS rate [ Time Frame: once, at enrollment (baseline) ]QNS rate of CFQT compared to GCQPIT

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | Child, Adult, Older Adult |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- clinical diagnosis of cystic fibrosis
- patients who require a sweat test
Exclusion Criteria:
- Infants less than 48 hours of age
- Patient is receiving oxygen by open delivery
- collection site has diffuse inflammation or rash

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01345617
United States, Minnesota | |
University of Minnesota | |
Minneapolis, Minnesota, United States, 55455 | |
United States, Utah | |
University of Utah | |
Salt Lake City, Utah, United States, 84012 | |
United States, Wisconsin | |
American Family Children's Hospital | |
Madison, Wisconsin, United States, 53792 |
Principal Investigator: | Michael J Rock, MD | University of Wisconsin, Madison |
Responsible Party: | Polychrome Medical, Inc. |
ClinicalTrials.gov Identifier: | NCT01345617 |
Other Study ID Numbers: |
2011-0291 CFQuantum001 ( Other Identifier: PolyChrome Medical, Inc. ) |
First Posted: | May 2, 2011 Key Record Dates |
Last Update Posted: | August 29, 2018 |
Last Verified: | August 2018 |
Cystic Fibrosis Pancreatic Diseases Digestive System Diseases Lung Diseases |
Respiratory Tract Diseases Genetic Diseases, Inborn Infant, Newborn, Diseases |